Background illustration for clinical trials search

Kidney Cancer Clinical Trials

Browse 251 kidney cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pencil Beam Scanning in Patients With Renal Tumors

for
Renal Tumor, Wilms Tumor
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 30

Code: NCT03810651

Early_phase1, Recruiting

SABR for Renal Tumors

for
Renal Tumor
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03747133

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

for
Hereditary Leiomyomatosis and Renal Cell Carcinoma,
Location: Bethesda MD, Columbus OH, Atlanta GA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT04981509

Phase2, Recruiting

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

for
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT04974671

Phase2, Recruiting

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

for
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer
Location: Aurora CO, Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06432036

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: Boston MA, Quebec, Bay Shore NY, Commack NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase2, Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

for
Solid Tumors, Advanced Cancer, Renal Cancer, Gastric Cancer,
Location: Montreal, Hershey PA, Chapel Hill NC, Toronto,
Sponsor: Apollomics Inc.

Sex: All

Age: 18+

Code: NCT03175224

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

for
Advanced Clear Cell Renal Cell Carcinoma,
Location: Duarte CA
Sponsor: Osel, Inc.

Sex: All

Age: 18+

Code: NCT06399419

Phase1, Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04510597

Phase3, Recruiting

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

for
Cancer, All Types, Cancer of Liver, Cancer of Stomach,
Location: Gainesville GA
Sponsor: SpeciCare

Sex: All

Age: 0 - 70+

Code: NCT03896958

Recruiting
New

Casdatifan for the Treatment of Refractory Metastatic Clear Cell Renal Cell Carcinoma

for
Refractory Clear Cell Renal Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT07748988

Phase1, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase2, Phase3, Recruiting

KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors (CCS)

for
Childhood Cancer, Chronic Kidney Diseases, Hypertension,
Location: Toronto
Sponsor: The Hospital for Sick Children

Sex: All

Age: 0 - 19

Code: NCT06153147

Recruiting
New

Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer

for
Locally Advanced Bladder Urothelial Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07667335

Phase1, Phase2, Recruiting

Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief

for
Bone Metastases, Prostate Cancer, Breast Cancer,
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT04177056

Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Hackensack NJ, Montreal, Hamilton, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

64Cu-GRIP B in Patients With Advanced Malignancies

for
Prostate Cancer, Renal Cancer, Urethral Cancer,
Location: San Francisco CA
Sponsor: Rahul Aggarwal

Sex: All

Age: 18+

Code: NCT05888532

Phase1, Phase2, Recruiting

Daily Hand-Held Vibration Therapy

for
Neuropathy, Cancer, Chemotherapeutic Drug - Induced Nephropathy,
Location: Indianapolis IN, Avon IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT04207437

Recruiting

A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

for
Secondary Hyperparathyroidism, Chronic Kidney Disease
Location: Philadelphia PA, Cleveland OH, Kansas City MO,
Sponsor: Amgen

Sex: All

Age: 0 - 18

Code: NCT03633708

Phase3, Recruiting